| Q37829930 | A hypothesis of calcium stone formation: an interpretation of stone research during the past decades |
| Q71903490 | Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone protein matrix |
| Q71895064 | Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine |
| Q72063416 | Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development |
| Q45057670 | Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers |
| Q45774232 | Crystal-matrix relationships in experimentally induced urinary calcium oxalate monohydrate crystals, an ultrastructural study |
| Q43976443 | Developmental morphology of calcium oxalate foreign body stones in rats |
| Q71566348 | Distribution of organic matrix in calcium oxalate renal calculi |
| Q67997479 | Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine |
| Q67247191 | Effects of serum, albumin and immunoglobulins on urease-induced crystallization in urine |
| Q67247156 | Effects of urinary macromolecules on the crystallization of calcium oxalate |
| Q35884937 | Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla |
| Q40661769 | Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones |
| Q72383563 | Inhibition of Calcium Oxalate Crystallisation by Pentosan Polysulphate in Control Subjects and Stone Formers |
| Q46979143 | Morphology of crystals in calcium oxalate monohydrate kidney stones |
| Q72685520 | The paradox of inhibition and enhancement of the formation of urinary stones |
| Q67247164 | Urinary crystal surface binding substances on calcium oxalate crystals |